2010/732/EU: Commission Decision of 30 November 2010 approving certain amended programmes for the eradication and monitoring of animal diseases and zoonoses for the year 2010 and amending Decision 2009/883/EC as regards the financial contribution by the Union for programmes approved by that Decision (notified under document C(2010) 8290)

The amended programme for the eradication of bovine brucellosis submitted by Portugal on 25 May 2010 is hereby approved for the period from 1 January 2010 to 31 December 2010.

The following amended programmes for the monitoring and eradication of bluetongue in endemic or high-risk areas are hereby approved for the period from 1 January 2010 to 31 December 2010: (a) the programme submitted by Spain on 17 May 2010; (b) the programme submitted by the Netherlands on 20 September 2010; (c) the programme submitted by Austria on 29 March 2010; (d) the programme submitted by Portugal on 12 May 2010.

The following amended programmes for the eradication of rabies are hereby approved for the period from 1 January 2010 to 31 December 2010: (a) the programme submitted by Bulgaria on 29 September 2010; (b) the programme submitted by Poland on 28 September 2010.

‘2 The financial contribution by the Union shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 for the costs of carrying out tuberculin and laboratory tests and the compensation to owners for the value of their animals slaughtered subject to those programmes, and shall not exceed: (a) EUR 12500000 for Ireland; (b) EUR 10100000 for Spain; (c) EUR 2800000 for Italy; (d) EUR 1000000 for Portugal; (e) EUR 27000000 for the United Kingdom.’;

‘2 The financial contribution by the Union shall be at the rate of 100 % of the costs to be incurred by each Member State referred to in paragraph 1 for carrying out rapid tests in animals as referred to in Article 12 paragraph 2 of Regulation (EC) No 999/2001, Annex III Chapter A Parts I and II points 1 to 5 of Regulation (EC) No 999/2001 and Annex VII to that Regulation, confirmatory tests and primary molecular discriminatory tests as referred to in of Annex X Chapter C point 3(2)(c)(i) of Regulation (EC) No 999/2001 and at the rate of 50 % of the cost incurred by each Member State for the compensation to owners for the value of their animals culled and destroyed in accordance with their BSE and scrapie eradication programmes and at a rate of 50 % of the cost of the analysis of samples for genotyping, and shall not exceed: (a) EUR 2340000 for Belgium; (b) EUR 440000 for Bulgaria; (c) EUR 1380000 for the Czech Republic; (d) EUR 1420000 for Denmark; (e) EUR 11260000 for Germany; (f) EUR 300000 for Estonia; (g) EUR 4700000 for Ireland; (h) EUR 2000000 for Greece; (i) EUR 6480000 for Spain; (j) EUR 16980000 for France; (k) EUR 7210000 for Italy; (l) EUR 70000 for Cyprus; (m) EUR 360000 for Latvia; (n) EUR 700000 for Lithuania; (o) EUR 100000 for Luxembourg; (p) EUR 1230000 for Hungary; (q) EUR 30000 for Malta; (r) EUR 3370000 for the Netherlands; (s) EUR 1510000 for Austria; (t) EUR 4930000 for Poland; (u) EUR 1640000 for Portugal; (v) EUR 1000000 for Romania; (w) EUR 240000 for Slovenia; (x) EUR 650000 for Slovakia; (y) EUR 610000 for Finland; (z) EUR 970000 for Sweden; (za) EUR 5920000 for the United Kingdom.’;

‘2 The financial contribution by the Union shall be at the rate of 75 % of the costs to be incurred by each Member State referred to in paragraph 1 for the cost of carrying out laboratory tests for the detection of rabies antigen or antibodies, the isolation and characterisation of the rabies virus, the detection of biomarker and the titration of vaccine baits, and for the purchase and distribution of vaccine plus baits for the programmes, and shall not exceed: (a) EUR 1870000 for Bulgaria; (b) EUR 680000 for Hungary; (c) EUR 7380000 for Poland; (d) EUR 820000 for Romania; (e) EUR 490000 for Slovakia.

3 The maximum of the costs to be reimbursed to the Member States for the programmes referred to in paragraph 1 shall on average not exceed: (a) for a serological test: EUR 12 per test; (b) for a test to detect tetracycline in bone: EUR 12 per test; (c) for a fluorescent antibody test (FAT): EUR 18 per test.’;

‘2 The financial contribution by the Union to the programmes referred to in paragraph 1 shall be at the rate of 50 % of the costs to be incurred by the concerned Member State for the cost of laboratory tests, and shall not exceed: (a) EUR 25000 for Bulgaria; (b) EUR 300000 for Hungary; (c) EUR 1000000 for Poland; (d) EUR 700000 for Spain.’;

‘3 The financial contribution by the Union shall be at the rate of 75 % of the costs to be incurred by each Member State referred to in paragraphs 1 and 2 for the cost of carrying out laboratory tests for the detection of rabies antigen or antibodies, the characterisation of the rabies virus, the detection of biomarker, age determination and the titration of vaccine baits, and for the purchase and distribution of vaccine plus baits for the programmes, and shall not exceed: (a) EUR 1360000 for Estonia; (b) EUR 1400000 for Latvia; (c) EUR 540000 for Lithuania; (d) EUR 200000 for Austria; (e) EUR 830000 for Slovenia; (f) EUR 150000 for Finland.

4 The maximum of the costs to be reimbursed to the Member States for the programmes referred to in paragraphs 1 and 2 shall on average not exceed: (a) for a serological test: EUR 12 per test; (b) for a test to detect tetracycline in bone: EUR 12 per test; (c) for a fluorescent antibody test (FAT): EUR 18 per test.’;

This Decision is addressed to the Member States.